Clinical Study
Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer
Table 3
Adverse event after DEB-TACE.
| AE | All grades number of events | Severe grade number of events | Percent event (all grades); |
| Nausea | 8 | 0 | 30 | Vomiting | 6 | 0 | 22 | Fatigue | 9 | 0 | 33 | Ascites | 6 | 1 (16.5%) | 22 | Anorexia | 2 | 0 | 7.5 | HTN | 1 | 0 | 3.5 | Skin rash | 1 | 0 | 3.5 | Pain | 16 | 5 (31.5%) | 60 | Infection | 1 | 1 (100%) | 3.5 | Allergic rxn. | 1 | 1 (100%) | 3.5 |
| Total | 51 | 8 | ā |
|
|